Skip to main content
. 2022 Apr 13;13:855976. doi: 10.3389/fimmu.2022.855976

Figure 3.

Figure 3

Data summary in dbPepNeo2.0. (A) The percentage of neoantigen data collected from different sources in dbPepNeo2.0. (B) Number of HC, MC neoantigens, and TCRs in two versions of dbPepNeo. (C) Number of LC immunopeptidomes in two versions of dbPepNeo. (D) Tumor type of class I HC neoantigens. (E) Tumor type of class II high-confidence neoantigens.